Cotadutide, a GLP-1 and Gcg receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
Genetic Predispositions and Personalized Treatment Selection Emerging evidence suggests genetic variation in GLP-1 receptor pathways, FTO, and MC4R genes may influence individual response to GLP-1 medications
Understand Berberine and Tirzepatide Mechanisms Understand Berberine and Tirzepatide Mechanisms Berberine : This natural compound is classified as a dietary supplement and activates AMP-activated protein kinase (AMPK)
CKD is often not detected until it has reached an advanced stage (NIH 2008
Keeping a brief log of hunger levels, timing relative to injections, and any associated factors (sleep quality, stress, specific foods eaten) provides valuable information for your healthcare team